| J&J Locks Theravance’s Phase I Inflammatory Bowel Disease Asset for US$1 B |
Abstract
pdf
html
|
|
Natasha Berry |
|
| BMS Inks US$3.63 B Immuno-Oncology Collaboration with Nektar Therapeutics |
Abstract
html
pdf
|
|
Arun Manohar |
|
| Idera and BioCryst Merge to Form Rare Disease Company |
Abstract
html
pdf
|
|
Natasha Piper |
|
| Seattle Genetics Strengthens Pipeline with Acquisition of Cascadian for US$614 M |
Abstract
pdf
html
|
|
Arun Manohar |
|
| Sanofi Makes Second Big Buy of the Month with Ablynx Acquisition |
Abstract
pdf
html
|
|
Natasha Piper |
|
| Roche Acquires Oncology Data Specialist Flatiron in US$1.9 B Deal |
Abstract
pdf
html
|
|
Jawala Prasad |
|
